This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Third View: Discussing the clinical data for 4D-150 and the design of the 4FRONT Phase 3 program presented at the 4D-150 Wet AMD Development Day.

Ticker(s): FDMT

Who's the expert?

Institution: Keystoen Retina Associates

  • Manages around 1200 patients for Wet AMD 
  • Specializes in cataract, retina, and neuro ophthalmology

Interview Goal
The goal of this conversation is to discuss the clinical data for the 4D-150 in the treatment of wet AMD.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.